Breaking News Instant updates and real-time market news.

TW

Tradeweb Markets

$87.04 /

-0.41 (-0.47%)

07:25
10/28/21
10/28
07:25
10/28/21
07:25

Tradeweb Markets reports Q3 EPS 39c, consensus 39c

Reports Q3 revenue $265.3M, consensus $263.38. "Tradeweb's strong momentum from the first half of the year continued through the third quarter of 2021, producing our second-best revenue quarter ever. Growth in trading volume was broad-based across our markets, with U.S. Credit, global swaps and U.S. Treasuries leading the way. We were delighted to welcome Sara Furber as our new CFO, helping us navigate Tradeweb's next phase of growth and development. Finally, we published our inaugural Corporate Sustainability Report to increase transparency for our strong foundation in ESG."

  • 28

    Oct

TW Tradeweb Markets
$87.04 /

-0.41 (-0.47%)

07/15/21 JPMorgan
Tradeweb Markets price target raised to $96 from $85 at JPMorgan
07/12/21 Deutsche Bank
Tradeweb Markets price target raised to $85 from $77 at Deutsche Bank
07/12/21 Piper Sandler
Tradeweb Markets price target raised to $80 from $79 at Piper Sandler
06/24/21 Credit Suisse
Tradeweb Markets assumed with an Outperform at Credit Suisse

TODAY'S FREE FLY STORIES

Earnings
Methode Electronics cuts FY22 EPS guidance to $3.00-$3.20 from $3.35-$3.75 » 07:10
12/02/21
12/02
07:10
12/02/21
07:10
MEI

Methode Electronics

$44.84 /

+0.43 (+0.97%)

one estimate $3.15. Cuts…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
MEI Methode Electronics
$44.84 /

+0.43 (+0.97%)

MEI Methode Electronics
$44.84 /

+0.43 (+0.97%)

Recommendations
Synopsys price target raised to $402 from $350 at Baird » 07:10
12/02/21
12/02
07:10
12/02/21
07:10
SNPS

Synopsys

$335.13 /

-5.85 (-1.72%)

Baird analyst Joe Vruwink…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
SNPS Synopsys
$335.13 /

-5.85 (-1.72%)

SNPS Synopsys
$335.13 /

-5.85 (-1.72%)

11/29/21 Credit Suisse
Synopsys price target raised to $360 from $300 at Credit Suisse
11/23/21 Wells Fargo
Synopsys price target raised to $400 from $340 at Wells Fargo
10/20/21 Needham
Synopsys initiated with a Buy at Needham on expected EDA industry growth
10/19/21 Needham
Synopsys initiated with a Buy at Needham
SNPS Synopsys
$335.13 /

-5.85 (-1.72%)

SNPS Synopsys
$335.13 /

-5.85 (-1.72%)

SNPS Synopsys
$335.13 /

-5.85 (-1.72%)

General news
Oil Action: WTI crude » 07:10
12/02/21
12/02
07:10
12/02/21
07:10
$ECON

Economic Data

/

+

Oil Action: WTI crude is…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
$ECON Economic Data
/

+

$ECON Economic Data
/

+

$ECON Economic Data
/

+

$ECON Economic Data
/

+

Hot Stocks
El Pollo Loco launches Loco Gifts and Gear store » 07:09
12/02/21
12/02
07:09
12/02/21
07:09
LOCO

El Pollo Loco

$12.17 /

-0.53 (-4.17%)

El Pollo Loco announced…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
LOCO El Pollo Loco
$12.17 /

-0.53 (-4.17%)

LOCO El Pollo Loco
$12.17 /

-0.53 (-4.17%)

11/12/21 Benchmark
El Pollo Loco initiated with a Hold at Benchmark
02/08/21 Truist
El Pollo Loco downgraded to Hold from Buy at Truist
02/08/21 Truist
El Pollo Loco downgraded to Hold from Buy at Truist
LOCO El Pollo Loco
$12.17 /

-0.53 (-4.17%)

Hot Stocks
Chemomab Therapeutics: FDA clears IND application for CM-101 » 07:09
12/02/21
12/02
07:09
12/02/21
07:09
CMMB

Chemomab Therapeutics

$8.51 /

-0.84 (-8.98%)

Chemomab Therapeutics…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
CMMB Chemomab Therapeutics
$8.51 /

-0.84 (-8.98%)

CMMB Chemomab Therapeutics
$8.51 /

-0.84 (-8.98%)

05/26/21 Cantor Fitzgerald
Chemomab Therapeutics initiated with an Overweight at Cantor Fitzgerald
05/07/21 Oppenheimer
Chemomab Therapeutics initiated with an Outperform at Oppenheimer
CMMB Chemomab Therapeutics
$8.51 /

-0.84 (-8.98%)

Earnings
Secureworks reports Q3 non-GAAP EPS 1c, consensus (6c) » 07:09
12/02/21
12/02
07:09
12/02/21
07:09
SCWX

Secureworks

$16.87 /

-0.88 (-4.96%)

Reports Q3 revenue…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
SCWX Secureworks
$16.87 /

-0.88 (-4.96%)

SCWX Secureworks
$16.87 /

-0.88 (-4.96%)

09/03/21 RBC Capital
Secureworks price target raised to $20 from $15 at RBC Capital
09/03/21 Barclays
Secureworks price target raised to $19 from $16 at Barclays
01/08/21 Morgan Stanley
Secureworks price target raised to $15 from $14 at Morgan Stanley
01/08/21 Goldman Sachs
Secureworks downgraded to Sell from Neutral at Goldman Sachs
SCWX Secureworks
$16.87 /

-0.88 (-4.96%)

  • 24
    Sep
Hot Stocks
Praxis Precision Medicines appoints Megan Sniecinski as CBO » 07:09
12/02/21
12/02
07:09
12/02/21
07:09
PRAX

Praxis Precision Medicines

$17.12 /

+ (+0.00%)

, BCRX

BioCryst

$11.28 /

-0.77 (-6.39%)

Praxis Precision…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
PRAX Praxis Precision Medicines
$17.12 /

+ (+0.00%)

BCRX BioCryst
$11.28 /

-0.77 (-6.39%)

PRAX Praxis Precision Medicines
$17.12 /

+ (+0.00%)

11/04/21 Wedbush
Praxis Precision Medicines price target lowered to $45 from $50 at Wedbush
08/26/21 BofA
Praxis Precision Medicines initiated with a Buy at BofA
04/26/21 William Blair
Praxis Precision Medicines initiated with an Outperform at William Blair
04/16/21 Piper Sandler
Praxis Precision Medicines transferred with Overweight at Piper Sandler
BCRX BioCryst
$11.28 /

-0.77 (-6.39%)

11/22/21 Piper Sandler
BioCryst financing lifts one of two overhangs, says Piper Sandler
11/04/21 Barclays
BioCryst price target lowered to $17 from $21 at Barclays
11/03/21 Piper Sandler
BioCryst earnings pullback a buying opportunity, says Piper Sandler
08/06/21 Jefferies
BioCryst downgraded to Hold from Buy at Jefferies
PRAX Praxis Precision Medicines
$17.12 /

+ (+0.00%)

BCRX BioCryst
$11.28 /

-0.77 (-6.39%)

  • 11
    Aug
  • 14
    May
BCRX BioCryst
$11.28 /

-0.77 (-6.39%)

BCRX BioCryst
$11.28 /

-0.77 (-6.39%)

Recommendations
Okta price target lowered to $230 from $265 at Baird » 07:08
12/02/21
12/02
07:08
12/02/21
07:08
OKTA

Okta

$197.91 /

-17.01 (-7.91%)

Baird analyst Jonathan…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
OKTA Okta
$197.91 /

-17.01 (-7.91%)

OKTA Okta
$197.91 /

-17.01 (-7.91%)

06:39 Today Mizuho
Okta price target lowered to $250 from $305 at Mizuho
04:41 Today Piper Sandler
Okta upgraded to Overweight from Neutral at Piper Sandler
11/18/21 DA Davidson
Okta initiated with a Buy at DA Davidson
11/15/21 Mizuho
Okta price target raised to $305 from $290 at Mizuho
OKTA Okta
$197.91 /

-17.01 (-7.91%)

OKTA Okta
$197.91 /

-17.01 (-7.91%)

OKTA Okta
$197.91 /

-17.01 (-7.91%)

OKTA Okta
$197.91 /

-17.01 (-7.91%)

Hot Stocks
Titan Mining declares special cash dividend of C$0.01 per share » 07:08
12/02/21
12/02
07:08
12/02/21
07:08
TNMCF

Titan Mining

/

+

Titan Mining Corporation…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
TNMCF Titan Mining
/

+

TNMCF Titan Mining
/

+

07/15/21 Canaccord
Titan Mining price target lowered to C$0.35 from C$0.65 at Canaccord
03/25/21 Canaccord
Titan Mining reinstated with a Hold at Canaccord
01/11/21 Scotiabank
Titan Mining price target raised to C$1 from C$0.60 at Scotiabank
01/06/21 National Bank
Titan Mining price target raised to C$0.90 from C$0.60 at National Bank
Initiation
Viant assumed with a Neutral at UBS » 07:08
12/02/21
12/02
07:08
12/02/21
07:08
DSP

Viant

$9.42 /

-0.31 (-3.19%)

UBS analyst Lloyd…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
DSP Viant
$9.42 /

-0.31 (-3.19%)

DSP Viant
$9.42 /

-0.31 (-3.19%)

07:06 Today UBS
Viant assumed with a Neutral at UBS
11/10/21 Canaccord
Viant price target lowered to $25 from $38 at Canaccord
09/27/21
Fly Intel: Top five analyst upgrades
09/27/21 JMP Securities
Viant upgraded to Outperform from Market Perform at JMP Securities
DSP Viant
$9.42 /

-0.31 (-3.19%)

  • 10
    Feb
DSP Viant
$9.42 /

-0.31 (-3.19%)

Hot Stocks
Chesapeake announces $1B common stock, warrant repurchase authorization » 07:07
12/02/21
12/02
07:07
12/02/21
07:07
CHK

Chesapeake

$57.02 /

-2.445 (-4.11%)

Chesapeake Energy…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
CHK Chesapeake
$57.02 /

-2.445 (-4.11%)

CHK Chesapeake
$57.02 /

-2.445 (-4.11%)

10/07/21
Fly Intel: Top five analyst initiations
10/07/21 UBS
Chesapeake initiated with a Buy at UBS
08/27/21
Fly Intel: Top five analyst initiations
08/27/21 BMO Capital
Chesapeake reinstated with an Outperform at BMO Capital
CHK Chesapeake
$57.02 /

-2.445 (-4.11%)

CHK Chesapeake
$57.02 /

-2.445 (-4.11%)

CHK Chesapeake
$57.02 /

-2.445 (-4.11%)

Hot Stocks
Karyopharm completes patient recruitment in Phase 3 endometrial cancer study » 07:07
12/02/21
12/02
07:07
12/02/21
07:07
KPTI

Karyopharm

$6.69 /

-0.25 (-3.60%)

Karyopharm completed…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
KPTI Karyopharm
$6.69 /

-0.25 (-3.60%)

KPTI Karyopharm
$6.69 /

-0.25 (-3.60%)

11/19/21 Morgan Stanley
Karyopharm assumed at Equal Weight from Overweight at Morgan Stanley
08/06/21 JPMorgan
JPMorgan double downgrades Karyopharm on Xpovio weakness
08/06/21 Baird
Karyopharm price target lowered to $17 from $30 at Baird
08/06/21 SVB Leerink
Karyopharm downgraded to Market Perform from Outperform at SVB Leerink
KPTI Karyopharm
$6.69 /

-0.25 (-3.60%)

KPTI Karyopharm
$6.69 /

-0.25 (-3.60%)

Earnings
Methode Electronics reports Q2 EPS 72c, one estimate 69c » 07:07
12/02/21
12/02
07:07
12/02/21
07:07
MEI

Methode Electronics

$44.84 /

+0.43 (+0.97%)

Reports Q2 revenue…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
MEI Methode Electronics
$44.84 /

+0.43 (+0.97%)

MEI Methode Electronics
$44.84 /

+0.43 (+0.97%)

Hot Stocks
Amdocs, G+D to provide eSIM managment for Orange Belgium » 07:06
12/02/21
12/02
07:06
12/02/21
07:06
DOX

Amdocs

$68.37 /

-1.52 (-2.17%)

Amdocs and…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
DOX Amdocs
$68.37 /

-1.52 (-2.17%)

DOX Amdocs
$68.37 /

-1.52 (-2.17%)

08/05/21 Oppenheimer
Amdocs price target raised to $99 from $84 at Oppenheimer
04/01/21 JPMorgan
Amdocs should 'bounce-back' after short report, says JPMorgan
03/31/21 JPMorgan
Prior Amdocs short report turned out a 'great buying opportunity,' says JPMorgan
02/11/21 Oppenheimer
Amdocs assumed with an Outperform at Oppenheimer
DOX Amdocs
$68.37 /

-1.52 (-2.17%)

Recommendations
Elastic price target lowered to $150 from $170 at Baird » 07:06
12/02/21
12/02
07:06
12/02/21
07:06
ESTC

Elastic

$138.88 /

-16.505 (-10.62%)

Baird analyst Jonathan…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
ESTC Elastic
$138.88 /

-16.505 (-10.62%)

ESTC Elastic
$138.88 /

-16.505 (-10.62%)

11/19/21 SMBC Nikko
Elastic downgraded to Neutral from Outperform at SMBC Nikko
09/17/21 Barclays
Elastic price target raised to $200 from $185 at Barclays
08/26/21 Oppenheimer
Elastic price target raised to $185 from $170 at Oppenheimer
08/26/21 Monness Crespi
Elastic price target raised to $230 from $212 at Monness Crespi
ESTC Elastic
$138.88 /

-16.505 (-10.62%)

ESTC Elastic
$138.88 /

-16.505 (-10.62%)

ESTC Elastic
$138.88 /

-16.505 (-10.62%)

Hot Stocks
Palantir awarded $43M contract from Space Systems Command » 07:05
12/02/21
12/02
07:05
12/02/21
07:05
PLTR

Palantir

$19.38 /

-1.27 (-6.15%)

Palantir Technologies…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
PLTR Palantir
$19.38 /

-1.27 (-6.15%)

PLTR Palantir
$19.38 /

-1.27 (-6.15%)

11/16/21
Fly Intel: Top five analyst initiations
11/16/21 Credit Suisse
Palantir initiated with a Neutral at Credit Suisse
11/10/21
Fly Intel: Top five analyst downgrades
11/10/21 Morgan Stanley
Morgan Stanley nudges up Palantir price target to $24 despite 'signs of slowing'
PLTR Palantir
$19.38 /

-1.27 (-6.15%)

PLTR Palantir
$19.38 /

-1.27 (-6.15%)

PLTR Palantir
$19.38 /

-1.27 (-6.15%)

PLTR Palantir
$19.38 /

-1.27 (-6.15%)

Earnings
Kirkland's sees Q4 earnings lower year-on-year, consensus $1.38 » 07:05
12/02/21
12/02
07:05
12/02/21
07:05
KIRK

Kirkland's

$20.58 /

-1.08 (-4.99%)

Expects a…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
KIRK Kirkland's
$20.58 /

-1.08 (-4.99%)

KIRK Kirkland's
$20.58 /

-1.08 (-4.99%)

10/15/21
Fly Intel: Top five analyst initiations
10/15/21 Benchmark
Kirkland's initiated with a Buy at Benchmark
09/03/21 Craig-Hallum
Kirkland's price target raised to $40 from $37 at Craig-Hallum
04/06/21 Sidoti
Kirkland's re-initiated with a Buy at Sidoti
KIRK Kirkland's
$20.58 /

-1.08 (-4.99%)

Recommendations
Wedbush sees $3 trillion market cap for Apple in 2022, ups price target » 07:05
12/02/21
12/02
07:05
12/02/21
07:05
AAPL

Apple

$164.67 /

-0.75 (-0.45%)

Wedbush analyst Daniel…

Wedbush analyst Daniel Ives raised the firm's price target on Apple to $200 from $185 and keeps an Outperform rating on the shares. The analyst has increased confidence in the iPhone 13 growth cycle into 2022 following channel checks. The checks "continue to be much stronger than expected" and Apple is now on pace to sell north of 40M iPhones during the holiday season despite the chip shortage headwinds, Ives tells investors in a research note. The analyst believes the underlying iPhone 13 demand story both domestically and in China "is trending well ahead of Street expectations." He estimates that in China alone there are roughly 15M iPhone 13 upgrades for the December quarter. Apple is on its way to three trillion dollar market cap during 2022 and is a "top tech name to own," contends Ives.

ShowHide Related Items >><<
AAPL Apple
$164.67 /

-0.75 (-0.45%)

AAPL Apple
$164.67 /

-0.75 (-0.45%)

12/01/21 UBS
Apple wait times showing 'modest' easing, says UBS
11/26/21 Wedbush
Wedbush sees Apple on pace to sell over 10M iPhones over Black Friday weekend
11/26/21
Apple to launch AR headset in 2022, TFI Asset's Kuo predicts
11/24/21 UBS
Apple demand remains strong, supply constraints improving, says UBS
AAPL Apple
$164.67 /

-0.75 (-0.45%)

AAPL Apple
$164.67 /

-0.75 (-0.45%)

AAPL Apple
$164.67 /

-0.75 (-0.45%)

AAPL Apple
$164.67 /

-0.75 (-0.45%)

AAPL Apple
$164.67 /

-0.75 (-0.45%)

Hot Stocks
GXO Logistics, MYXfitness announce opening of Atlanta distribution center » 07:04
12/02/21
12/02
07:04
12/02/21
07:04
GXO

GXO Logistics

$92.00 /

-3.94 (-4.11%)

, BODY

Beachbody Company

$2.51 /

-0.09 (-3.46%)

GXO Logistics (GXO) and…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
GXO GXO Logistics
$92.00 /

-3.94 (-4.11%)

BODY Beachbody Company
$2.51 /

-0.09 (-3.46%)

GXO GXO Logistics
$92.00 /

-3.94 (-4.11%)

11/23/21
Fly Intel: Top five analyst downgrades
11/23/21 Loop Capital
GXO Logistics downgraded to Hold from Buy at Loop Capital
11/23/21 Loop Capital
GXO Logistics downgraded to Hold from Buy at Loop Capital
11/17/21 BofA
XPO Logistics downgraded to Neutral at BofA amid LTL cost pressures
BODY Beachbody Company
$2.51 /

-0.09 (-3.46%)

11/17/21 Loop Capital
Beachbody Company downgraded to Sell at Loop Capital on 'alarming' cash burn
11/17/21 Loop Capital
Beachbody Company downgraded to Sell from Hold at Loop Capital
11/16/21 Guggenheim
Beachbody Company downgraded to Neutral from Buy at Guggenheim
11/16/21 Baird
Baird downgrades Beachbody Company to Neutral on reduced visibility
GXO GXO Logistics
$92.00 /

-3.94 (-4.11%)

BODY Beachbody Company
$2.51 /

-0.09 (-3.46%)

GXO GXO Logistics
$92.00 /

-3.94 (-4.11%)

BODY Beachbody Company
$2.51 /

-0.09 (-3.46%)

GXO GXO Logistics
$92.00 /

-3.94 (-4.11%)

BODY Beachbody Company
$2.51 /

-0.09 (-3.46%)

Recommendations
Crowdstrike price target lowered to $275 from $310 at Baird » 07:04
12/02/21
12/02
07:04
12/02/21
07:04
CRWD

Crowdstrike

$201.00 /

-15.92 (-7.34%)

Baird analyst Jonathan…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
CRWD Crowdstrike
$201.00 /

-15.92 (-7.34%)

CRWD Crowdstrike
$201.00 /

-15.92 (-7.34%)

06:53 Today Deutsche Bank
Crowdstrike price target lowered to $260 from $300 at Deutsche Bank
06:36 Today Mizuho
Crowdstrike price target lowered to $330 from $360 at Mizuho
11/24/21 Deutsche Bank
Crowdstrike price target lowered to $300 from $320 at Deutsche Bank
11/18/21
Fly Intel: Top five analyst initiations
CRWD Crowdstrike
$201.00 /

-15.92 (-7.34%)

CRWD Crowdstrike
$201.00 /

-15.92 (-7.34%)

CRWD Crowdstrike
$201.00 /

-15.92 (-7.34%)

CRWD Crowdstrike
$201.00 /

-15.92 (-7.34%)

Hot Stocks
Palantir, Kinder Morgan announce multi-year partnership » 07:04
12/02/21
12/02
07:04
12/02/21
07:04
PLTR

Palantir

$19.38 /

-1.27 (-6.15%)

, KMI

Kinder Morgan

$15.26 /

-0.21 (-1.36%)

Palantir Technologies…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
PLTR Palantir
$19.38 /

-1.27 (-6.15%)

KMI Kinder Morgan
$15.26 /

-0.21 (-1.36%)

PLTR Palantir
$19.38 /

-1.27 (-6.15%)

11/16/21
Fly Intel: Top five analyst initiations
11/16/21 Credit Suisse
Palantir initiated with a Neutral at Credit Suisse
11/10/21
Fly Intel: Top five analyst downgrades
11/10/21 Morgan Stanley
Morgan Stanley nudges up Palantir price target to $24 despite 'signs of slowing'
KMI Kinder Morgan
$15.26 /

-0.21 (-1.36%)

09/28/21 BofA
BofA reinstates coverage of U.S. Midstream sector with six buys, four sells
09/28/21 BofA
Kinder Morgan reinstated with a Neutral at BofA
07/22/21 Mizuho
Kinder Morgan price target raised to $22 from $21 at Mizuho
06/17/21 Piper Sandler
Kinder Morgan price target raised to $19 from $17 at Piper Sandler
PLTR Palantir
$19.38 /

-1.27 (-6.15%)

KMI Kinder Morgan
$15.26 /

-0.21 (-1.36%)

PLTR Palantir
$19.38 /

-1.27 (-6.15%)

KMI Kinder Morgan
$15.26 /

-0.21 (-1.36%)

PLTR Palantir
$19.38 /

-1.27 (-6.15%)

KMI Kinder Morgan
$15.26 /

-0.21 (-1.36%)

PLTR Palantir
$19.38 /

-1.27 (-6.15%)

KMI Kinder Morgan
$15.26 /

-0.21 (-1.36%)

Hot Stocks
Acasti Pharma announces interim data meets primary endpoints in PK study » 07:04
12/02/21
12/02
07:04
12/02/21
07:04
ACST

Acasti Pharma

$1.27 /

-0.06 (-4.51%)

Acasti Pharma announced…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
ACST Acasti Pharma
$1.27 /

-0.06 (-4.51%)

ACST Acasti Pharma
$1.27 /

-0.06 (-4.51%)

Recommendations
U.S. Gold price target raised to $25 from $20 at Alliance Global Partners » 07:03
12/02/21
12/02
07:03
12/02/21
07:03
USAU

U.S. Gold

/

+

Alliance Global Partners…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
USAU U.S. Gold
/

+

USAU U.S. Gold
/

+

04/08/21 Alliance Global Partners
U.S. Gold price target lowered to $20 from $25 at Alliance Global Partners
01/11/21 Alliance Global Partners
U.S. Gold initiated with a Buy at Alliance Global Partners
Earnings
Kirkland's reports Q3 adjusted EPS 51c, consensus 56c » 07:03
12/02/21
12/02
07:03
12/02/21
07:03
KIRK

Kirkland's

$20.58 /

-1.08 (-4.99%)

Reports Q3 revenue…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
KIRK Kirkland's
$20.58 /

-1.08 (-4.99%)

KIRK Kirkland's
$20.58 /

-1.08 (-4.99%)

10/15/21
Fly Intel: Top five analyst initiations
10/15/21 Benchmark
Kirkland's initiated with a Buy at Benchmark
09/03/21 Craig-Hallum
Kirkland's price target raised to $40 from $37 at Craig-Hallum
04/06/21 Sidoti
Kirkland's re-initiated with a Buy at Sidoti
KIRK Kirkland's
$20.58 /

-1.08 (-4.99%)

Hot Stocks
TScan Therapeutics establishes facility to manufacture T Cell Therapies » 07:03
12/02/21
12/02
07:03
12/02/21
07:03
TCRX

TScan Therapeutics

$7.02 /

-0.63 (-8.24%)

, BXP

Boston Properties

$105.24 /

-2.73 (-2.53%)

TScan Therapeutics (TCRX)…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
TCRX TScan Therapeutics
$7.02 /

-0.63 (-8.24%)

BXP Boston Properties
$105.24 /

-2.73 (-2.53%)

TCRX TScan Therapeutics
$7.02 /

-0.63 (-8.24%)

08/13/21 Cowen
Cowen sees upside for TScan Therapeutics, starts with Outperform
08/13/21 Cowen
TScan Therapeutics initiated with an Outperform at Cowen
08/10/21 Jefferies
TScan Therapeutics initiated with a Buy at Jefferies
08/10/21 Morgan Stanley
TScan Therapeutics initiated with an Overweight at Morgan Stanley
BXP Boston Properties
$105.24 /

-2.73 (-2.53%)

10/26/21
Boston Properties sees FY21 FFO $6.50-$6.52, consensus $6.61
09/01/21 Barclays
Boston Properties initiated with an Overweight at Barclays
09/01/21 Piper Sandler
Boston Properties price target raised to $140 from $135 at Piper Sandler
08/02/21 Argus
Boston Properties price target raised to $132 from $120 at Argus
TCRX TScan Therapeutics
$7.02 /

-0.63 (-8.24%)

BXP Boston Properties
$105.24 /

-2.73 (-2.53%)

  • 16
    Jul
BXP Boston Properties
$105.24 /

-2.73 (-2.53%)

TCRX TScan Therapeutics
$7.02 /

-0.63 (-8.24%)

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.